Product Details
Product Details
Product Specification
| Host | Rabbit |
| Antigen | TNF-β |
| Clone Number | S-3689 |
| Antibody Type | Recombinant mAb |
| Isotype | IgG |
| Application | ELISA |
| Reactivity | Hu |
| Purification | Protein A |
| Concentration | 0.5 mg/ml |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300 |
| Stability & Storage | 12 months from date of receipt / reconstitution, -20 °C as supplied |
Dilution
| application | dilution | species |
| ELISA | 1:5000-1:10000 | Hu |
Background
Human Tumor Necrosis Factor-beta (TNF-β), also known as lymphotoxin-alpha (LT-α), is a pro-inflammatory cytokine primarily secreted by activated lymphocytes, including T cells, B cells, and NK cells. It signals through the TNF receptor 1 (TNFR1) and TNFR2, activating downstream pathways such as NF-κB, MAPK, and apoptosis cascades, which regulate immune responses and inflammation. Unlike TNF-α, which is produced by macrophages and other innate immune cells, TNF-β plays a specialized role in lymphoid organ development, host defense, and autoimmune pathogenesis. It contributes to the formation of secondary lymphoid structures and promotes cytotoxic T cell and B cell functions. Dysregulated TNF-β expression is associated with chronic inflammatory diseases, including rheumatoid arthritis and multiple sclerosis, making it a potential therapeutic target. Its dual role in immune regulation and pathology underscores its significance in both physiological and disease contexts.
